Dr. Boyeon Kim: DNA Sequencer Backs IPMI(Invites Precision Medicine Initiative)

Dr. Boyeon Kim, Managing Director at Invites Genomics, shared her enthusiasm for joining the genome project #IPMI (Invites Precision Medicine Initiative) to deepen our understanding of the #Korean population.
She also offered valuable insights into sequencer selection, emphasizing the importance of high-throughput and data quality stability. She remarked that DNBSEQ-T7 meets these rigorous standards to help their research.
#genomics